source
- FDA rejects ivonescimab for lung cancer; J&J to acquire Ollin Biosciences for up to $3.3B, Senate votes on FDA commissionerThe FDA has denied the application for ivonescimab as a treatment for lung cancer, halting its development for that indication. Johnson & Johnson announced a deal to purchase Ollin Biosciences, a…
- Trump administration proposes new Medicare Advantage audit rule aiming to curb fraud and save $90 billionThe Trump administration on Monday proposed new regulations that would reissue Biden-era rules and focus on more aggressive audits of Medicare Advantage plans to combat fraud. Officials say the ru…